Drugs that contain Darifenacin Hydrobromide
1. Enablex patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5096890 | ABBVIE | Pyrrolidine derivatives |
Mar, 2015
(9 years ago) | |
| US6106864 | ABBVIE | Pharmaceutical formulations containing darifenacin |
Aug, 2016
(7 years ago) | |
Market Authorisation Date: 22 December, 2004
Treatment: Treating a disease of altered motility or tone of smooth muscle by administering a muscarinic receptor antagonizing amount of darifenacin; Treating urinary incontinence by administering an extended-re...
Dosage: TABLET, EXTENDED RELEASE;ORAL
How can I launch a generic of ENABLEX before it's drug patent expiration?
More Information on Dosage
ENABLEX family patents
